Development of the 99m Tc-Labelled SST 2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study.
Saved in:
| Title: | Development of the 99m Tc-Labelled SST 2 Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study. |
|---|---|
| Authors: | Novak, Doroteja1 (AUTHOR), Janota, Barbara2 (AUTHOR), Hörmann, Anton Amadeus3 (AUTHOR), Sawicka, Agnieszka2 (AUTHOR), Kroselj, Marko4,5 (AUTHOR), Hubalewska-Dydejczyk, Alicja6 (AUTHOR), Fani, Melpomeni7 (AUTHOR), Mikolajczak, Renata2 (AUTHOR), Kolenc, Petra1,4 (AUTHOR), Decristoforo, Clemens3 (AUTHOR) clemens.decristoforo@tirol-kliniken.at, Garnuszek, Piotr2 (AUTHOR) |
| Source: | Pharmaceutics. Mar2023, Vol. 15 Issue 3, p885. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
